Page 32 - Market Commitment News Today

8  PHNOM PENH, Cambodia – The United States congratulates Cambodia on the successful arrival of 324,000 doses of the AstraZeneca COVID-19 vaccine on March 2, 2021.  This shipment was made possible through the COVAX Advance Market Commitment, a global initiative to support equitable access to COVID-19 vaccines.  The United States recently announced the provision of an initial $2 billion—out of a total planned $4 billion— to the COVAX Advance Market Commitment, making the United St...

340,000 doses of COVAX vaccines due in Rwanda today Format Air freight carrying the AstraZeneca/Oxford SII vaccines supplied through the COVAX Facility arrives in Kigali. Pfizer-BioNTech vaccines expected to arrive later today. KIGALI, 03 March 2021 – Health workers and other priority populations vulnerable to COVID-19 can now expect to receive life-saving coronavirus vaccines in Rwanda as 240,000 doses of the AstraZeneca/Oxford vaccines licensed and manufactured by the Serum Institute of Ind...

The Ministry of Health will vaccinate civil servants in charge of collecting tax revenue from the General Department of Customs and Excise of Cambodia (GDCE) and the General Department of Taxation (GDT) at hospitals in the capital and provinces in the next phase of Covid-19 vaccinations. In reference to Prime Minister Hun Sen’s approval letter to the Ministry of Economy and Finance, the health ministry noted in a March 3 press release that the campaign would proceed on a voluntary basis and c...

First COVID-19 COVAX vaccine doses administered in Africa March 2, 2021 GENEVA / NEW YORK / OSLO – As the global rollout of COVAX vaccines accelerates, the first COVID-19 vaccination campaigns in Africa using COVAX doses began March 1, 2021, in Ghana and Côte d’Ivoire. These campaigns are among the first to use doses provided by the COVAX Facility’s Gavi COVAX Advanced Market Commitment (AMC). The AMC is the COVAX Facility’s mechanism to provide donor-funded vaccines to lower-inco...

Nigeria, on Tuesday received 3.94 million doses of the AstraZeneca/Oxford vaccine, manufactured by the Serum Institute of India (SII)

Coronavirus - Africa: First COVID-19 COVAX vaccine doses administered in Africa The first COVID-19 vaccination campaigns in Africa using COVAX doses began in Ghana and Côte dIvoire GENEVA, Switzerland, March 1, 2021/APO Group/ -- Today, the governments of Côte d’Ivoire and Ghana began COVID-19 vaccination campaigns aimed at protecting healthcare workers; This week’s first vaccinations happen as a further 11 million COVAX doses are expected to be delivered over the next seven days; Publica...

Today, the governments of Côte d’Ivoire and Ghana began COVID-19 vaccination campaigns aimed at protecting healthcare workers; This week’s first vaccinations happen as a further 11 million COVAX doses are expected to be delivered over the next seven days; Publication of the allocation of the AstraZeneca/Oxford vaccine to 142 of COVAX’s participating economies, to be […]

The disturbing trend of “vaccine nationalism” in which wealthy countries hoard Covid-19 medical supplies such as vaccines, will only serve to prolong the pandemic. Prime Minister Dr Ralph Gonsavles drove home this point in his address to the United Nations Security Council (UNSC) on Wednesday, February 17, titled “Ensuring Equitable Access for COVID-19 Vaccines in Contexts Affected by Conflict and Instability.” “The simple truth is that unless vaccines are made …

What is COVAX? How a global initiative is helping get COVID-19 vaccines to poorer countries • 13 min read What is COVAX? COVID-19 Vaccine Global Access is an initiative launched by the WHO to ensure vaccine access to the world’s most vulnerable.Francis Kokoroko/COVAX via Unicef LONDON -- As rich countries race to inoculate their populations against COVID-19, poorer nations have fallen behind in the biggest vaccination campaign in history. But a global vaccine-sharing scheme aims to ensure r...

What Is COVAX? COVID-19 Vaccines Global Access, better known as COVAX, is a global platform to support the development, manufacturing, and distribution of COVID-19 vaccines. It was launched in April 2020 by the World Health Organization (WHO), the European Commission, and France as one of the three pillars of the Access to COVID-19 Tool Accelerator. A crucial aspect of the initiative is the COVAX Facility, which is run by public-private global health partnership known as Gavi, the Vaccine Alli...